Stay updated on Odevixibat for Biliary Atresia Post-Kasai Clinical Trial
Sign up to get notified when there's something new on the Odevixibat for Biliary Atresia Post-Kasai Clinical Trial page.

Latest updates to the Odevixibat for Biliary Atresia Post-Kasai Clinical Trial page
- Check4 days agoChange DetectedThe Italy site entry was updated from Padua to Padova, replacing the English name with the local Italian name.SummaryDifference0.0%

- Check11 days agoChange DetectedAdds recent study record update dates (2026-04-01, 2026-03-31, 2026-03) and removes older dates (2026-03-02, 2026-02-27, 2026-02). These are administrative updates and do not modify core trial details.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This change does not modify study content or user-facing information.SummaryDifference0.0%

- Check40 days agoChange DetectedLocations section updated: added new sites (Taipei, Jerusalem, Munich, Brussels, North Adelaide, etc.) and increased total locations from 66 to 72.SummaryDifference0.7%

- Check61 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2, a minor update that does not affect study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Odevixibat for Biliary Atresia Post-Kasai Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Odevixibat for Biliary Atresia Post-Kasai Clinical Trial page.